This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Oculopharyngeal muscular dystrophy

Authoring team

Oculopharyngeal muscular dystrophy is an autosomal dominant condition usually evident in the fifth decade of life.

It is characterised by ptosis with progressive involvement of extraocular muscles until total paralysis of eye movements results. The pupillary reactions are spared.

Flaccid dysphagia, flaccid dysarthria, facial weakness and proximal limb weakness are late features.

Investigations reveal an elevated creatine phosphokinase - up to five times - and characteristic muscle biopsy - "rimmed" vacuoles in a proportion of muscle fibres.

Treatment is supportive. Dysphagia may require nasogastric feeding. Death usually results from infection.

It must be distinguished from myasthenia gravis and mitochondrial myopathy in which ptosis is also a distinctive feature.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.